Valeo Financial Advisors LLC Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Valeo Financial Advisors LLC raised its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 2.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,457 shares of the company’s stock after buying an additional 95 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Clorox were worth $493,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CLX. Tyler Stone Wealth Management bought a new position in shares of Clorox during the 2nd quarter valued at approximately $25,000. Strategic Investment Solutions Inc. IL bought a new position in Clorox during the first quarter valued at $31,000. Fortitude Family Office LLC purchased a new stake in shares of Clorox in the fourth quarter valued at $29,000. First Capital Advisors Group LLC. bought a new stake in shares of Clorox in the 2nd quarter worth about $35,000. Finally, American National Bank boosted its stake in shares of Clorox by 2,466.7% during the 3rd quarter. American National Bank now owns 231 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 1.9 %

Shares of NYSE CLX opened at $141.98 on Monday. The stock has a market capitalization of $17.62 billion, a PE ratio of 225.37, a price-to-earnings-growth ratio of 2.21 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21. The stock’s fifty day simple moving average is $151.19 and its two-hundred day simple moving average is $141.52.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.98 earnings per share. As a group, analysts expect that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.38%. Clorox’s payout ratio is 761.90%.

Analyst Ratings Changes

A number of analysts recently weighed in on CLX shares. UBS Group increased their price objective on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Morgan Stanley reissued an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research note on Tuesday, March 26th. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Barclays decreased their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research report on Wednesday, April 10th. Finally, JPMorgan Chase & Co. upped their price target on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a report on Thursday, January 18th. Four equities research analysts have rated the stock with a sell rating and twelve have given a hold rating to the company. According to data from MarketBeat, Clorox currently has an average rating of “Hold” and a consensus price target of $149.13.

Read Our Latest Research Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.